Markers of Prognosis and Response to Therapy in Patients With Metastatic Brain Tumors Undergoing Stereotactic Radiosurgery (SRS)

Status unconfirmed

Conditions studied: Metastatic Brain Tumor

In brief

This registry study will evaluate patients with metastatic brain tumors undergoing, or having undergone, stereotactic radiosurgery (SRS) at Swedish Medical Center. Clinical outcomes will be evaluated at the 3, 6 and 12-month time points. Clinical data, SRS treatment data, and imaging data (including anatomic and advanced imaging sequences obtained prior to and serially following SRS) will be archived in an online informatics platform, specifically a metastatic brain tumor registry known as the Comprehensive Neuro-oncology Data Repository for Metastatic Tumors (CONDR - Mets).

Key facts

Study ID

NCT01908179

Run by

Swedish Medical Center

People needed

100

Starts

2013-01-01

Last updated by the study team

2013-07-25

Who can join

Age: 19 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (>18 yo) with a pathological diagnosis of metastatic brain cancer
• Participants must have >4 tumors felt to require stereotactic radiosurgery
• Karnofsky scale of > 70 at the time of initial treatment
• Age < 80

You may not qualify if…

• Karnofsky scale <70
• Age > 80
• Inability to undergo MR imaging studies

Where it is running

• Swedish Medical Center — Seattle, Washington, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.